STAT+: With a legislative veto, Maryland’s prescription drug affordability board moves forward
Following a vote by the Maryland House of Delegates, the state now has all the…
Category: drug pricing
STAT+: Drug maker will slash prices on cancer medicines to end price gouging probe in Europe
After months of deliberation, the European Commission has accepted an offer from Aspen Pharma to…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: House Democrats slip drug-pricing proposal into Covid-19 relief bill
WASHINGTON — House Democrats are expected to insert a controversial Medicaid drug pricing policy into…
Opinion: The Biden administration needs to look beyond ICER for evaluating drug therapies
As breakthrough drugs stream out of biopharmaceutical laboratories, how much they should cost and who…
STAT+: Pharmacy benefit managers take heavy criticism from a new source: local officials
In what is being described as an unusual move, a Pennsylvania county is openly blaming…
STAT+: Biden administration pumps brakes on signature Trump drug pricing proposal
WASHINGTON — The Biden administration has agreed to delay for a year the implementation of…
.jpg)
STAT+: U.S. drug prices were more than double those in dozens of countries in 2018
As debate intensifies over the cost of medicines, a new analysis found that prescription drug…
STAT+: Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries
Like the proverbial tortoise, a new analysis finds that while the pharmaceutical industry is taking…
STAT+: This professor wrote a manual for using a little-known federal law for lowering drug prices
One of the priorities of the new Biden administration is to tackle the cost of…
STAT+: Canada’s drug makers rattle their sabers over a government plan to control medicine spending
A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug…
STAT+: The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss
In a surprise move, Mark Cuban last week announced plans to enter the generic drug…
STAT+: How much? Hospitals mark up some medicines by 250% on average
As Americans grapple with the rising cost of prescription drugs, a new analysis found that…
STAT+: Will the FTC get tougher on pharma business practices under the Biden administration?
As the Biden administration begins setting priorities, the Federal Trade Commission is poised to take…
STAT+: Maryland Senate overrides governor’s veto of prescription drug affordability board
In response to the rising cost of medicines, the Maryland state Senate overrode a veto…
.jpg)
STAT+: Medicare Part D spent twice what the VA paid for the same drugs
Medicare Part D spent more than twice as much on hundreds of prescription drugs than…
STAT+: Drug makers sue HHS over a discount program serving low-income populations
In a clutch of lawsuits, three drug makers argue the federal government is wrong to…
STAT+: Mark Cuban wades into the generic drug shark tank with a new company
Mark Cuban turns down new business opportunities on Shark Tank by declaring “I’m out!” But…
STAT+: Endocrinologists urge federal lawmakers to act to lower insulin costs
Amid ongoing concerns over the cost of insulin, a leading physicians group is calling for…
STAT+: Middlemen sue to block a signature Trump drug pricing proposal
WASHINGTON — The Pharmaceutical Care Management Association, which represents drug middlemen in Washington, filed a…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019
During 2019, drug makers raised prices on seven widely used medicines by substantial amounts without…
STAT+: Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices
In a little-noticed move, a Commerce Department unit has proposed a new rule that would…
STAT+: Company dedicated to cutting drug prices raises lots of money, releases few details
EQRx, a startup that made waves last year when it announced a plan to develop…
STAT+: Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal
WASHINGTON — Democrats have their best shot in more than a decade to deliver on…
STAT+: Tennessee to become the first state to run a closed Medicaid drug formulary
In a first-of-its-kind move, the Trump administration will allow Tennessee officials to restrict medicines covered…
STAT+: Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat
An arcane regulatory term known as skinny labeling may have a funny ring to it,…
STAT+: Pharma rings in the new year with 5% price hikes on hundreds of medicines
When it comes to prescription drug prices, what goes up often continues to go up…
STAT+: 3 pharma trends to watch in 2021
To say this past year has been like no other is an understatement. But for…
STAT+: Federal judge places restraining order on Trump’s latest drug pricing rule
WASHINGTON — A federal judge on Wednesday issued a temporary restraining order preventing one of…
STAT+: This tiny, one-drug biotech company is the loudest critic of Trump’s new international drug pricing policy
WASHINGTON — A tiny biosimilar company called Coherus Biosciences is emerging as one of the…
Opinion: Unaffordable prescription drugs: the real legacy of the Hatch-Waxman Act
How is it possible to have a prescription drug price crisis when 90% of prescriptions…
STAT+: State attorneys general urge HHS to penalize drug makers for cutting discounts to hospitals
More than two dozen state attorneys general are urging federal authorities to fine several large…
STAT+: Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
In a blow to pharmacy benefit managers, the U.S. Supreme Court ruled that an Arkansas…
STAT+: Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
As states struggle to control the cost of prescription medicines, a new report found pharmacy…
STAT+: Families tell U.N. Vertex is violating human rights with cystic fibrosis drug pricing
In an unusual move, a coalition of cystic fibrosis patients and their families have filed…
STAT+: 3 reasons the drug industry should be worried about Biden’s HHS pick, Xavier Becerra
WASHINGTON — For a pharmaceutical industry that has spent two years sparring with health secretary…
STAT+: FTC says the number of pay-to-delay cases remains low, but vows to keep watch
Although more drug makers are settling patent infringement lawsuits, the U.S. Federal Trade Commission found…
STAT+: With growing usage and few generics, Medicare spending on inhalers is climbing
Over a recent seven-year period, Medicare Part D spending on inhalers used to control respiratory…
STAT+: STAT+ Conversations: A conversation on drug pricing, policy, and access
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech…
STAT+: FDA spikes a drug approval program that inadvertently led to price hikes and shortages
After years of mounting criticism, the federal government is planning to end a controversial program…
STAT+: Medicines Patent Pool expands deal for access to key HIV drug to several countries
In a bid to expand access to a key AIDS drug, ViiV Healthcare and the…
STAT+: Which pricey drugs will Trump’s international pricing policy target?
A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
Opinion: Make list price the touchstone for drug pricing across the supply chain
In October, the House Oversight Committee turned a magnifying glass on the rising cost of…
STAT+: NIH fails to disclose enough details about drug licensing, watchdog report finds
Amid increasing debate over the cost of prescription drugs, a federal watchdog agency found the…
STAT+: Trump’s making last-minute drug pricing reforms — and surprisingly, Democrats want Biden to keep the biggest one
WASHINGTON — President-elect Joe Biden has already pledged to dismantle a number of Trump-era policies…
STAT+: Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs
Top of the morning to you and a fine one, it is. Blue skies and…
‘You just got better at making money’: Democrats blast Celgene, Teva for price hikes detailed in internal documents
WASHINGTON — A handful of newly elected Democrats, including Rashida Tlaib of Michigan, Ayanna Pressley…
STAT Plus: For the first time, drug makers and PBMs must jointly face an insulin price fixing lawsuit
A federal judge ruled that a Texas county can proceed with a lawsuit accusing several…
Congressional investigation reveals Celegene, Teva plotted to keep drug prices high
WASHINGTON — The House Oversight Committee released two major reports Wednesday that expose the internal…
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
WASHINGTON — Not only has he lowered drug prices, President Trump claimed in the first…